Daxor Corporation Common Stock
$11.63
-$0.08 (-0.73%)
$11.49Day Range$11.94
Key Statistics
Market Cap
$68.39M
Shares Outstanding
5.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 25, 1983
Round Lot
100
Locale
US
Trading Data
Day Open
$11.94
Day High
$11.94
Day Low
$11.49
Volume
31.1K
VWAP
$11.64
Prev Close
$11.71
Transactions
--
Acc. Volume
--
About Daxor Corporation Common Stock
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841750 employees350 FIFTH AVENUE, NEW YORK, NY, 10118(212) 244-0555IPO Jul 25, 1983US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000027367
- Composite FIGI
- BBG000BHHF34
- Share Class FIGI
- BBG001S5QPC8
- Ticker Root
- DXR
- SIC Code
- 3841
About Daxor Corporation Common Stock (DXR) Stock
Daxor Corporation Common Stock (DXR) closed the 2026-09-17 session at $11.63, down 0.73% versus the previous close (-0.08). The stock opened at $11.94 and traded between $11.49 and $11.94 during that session. Session trading volume was 31K shares. The volume-weighted average price (VWAP) is $11.64.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
Daxor Corporation Common Stock has a market capitalization of $68.4 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. DXR is listed on the XNAS exchange. The company employs approximately 750 people. Daxor Corporation Common Stock is headquartered in NEW YORK, NY. The recorded listing date is 1983-07-25.
On this page you can find market DXR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.